Neumora Therapeutics Files Q1 2025 10-Q
Ticker: NMRA · Form: 10-Q · Filed: May 12, 2025 · CIK: 1885522
| Field | Detail |
|---|---|
| Company | Neumora Therapeutics, INC. (NMRA) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Neumora's Q1 2025 10-Q is in. Check their cash and securities.
AI Summary
Neumora Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position, including marketable securities and cash equivalents. Key dates mentioned include the filing date of May 12, 2025, and the fiscal year end of December 31.
Why It Matters
This filing provides investors with an update on Neumora's financial health and asset holdings as of the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2025-03-31 — Reporting Date (Financials as of this date)
- 2025-05-12 — Filing Date (Date the report was submitted)
Key Players & Entities
- Neumora Therapeutics, Inc. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250512 (date) — Filing Date
- RBNC Therapeutics, Inc. (company) — Former Company Name
- 20210929 (date) — Date of Name Change
FAQ
What is the reporting period for this 10-Q filing?
The reporting period is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 12, 2025.
What was Neumora Therapeutics, Inc.'s former company name?
Neumora Therapeutics, Inc.'s former company name was RBNC Therapeutics, Inc.
When did the company change its name?
The company changed its name on September 29, 2021.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Neumora Therapeutics, Inc. (NMRA).